| Cell line name |
ABC-5 |
| Accession |
CVCL_UW52 |
| Resource Identification Initiative |
To cite this cell line use: ABC-5 (RRID:CVCL_UW52) |
| Comments |
Population: Japanese. Doubling time: 37.9 hours (PubMed=8286010). |
| Disease |
Lung adenocarcinoma (NCIt: C3512) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Sex unspecified |
| Age at sampling |
Age unspecified |
| Category |
Cancer cell line |
| Publications | PubMed=8286010 Katsuyuki Kiura, Shinobu Watarai, Takuo Shibayama, Taisuke Ohnoshi, Ikuro Kimura, Tatsuji Yasuda; Inhibitory effects of cholera toxin on in vitro growth of human lung cancer cell lines. Anticancer Drug Des. 8:417-428(1993) PubMed=10358721; DOI=10.18926/AMO/31626 Akio Matsushita, Masahiro Tabata, Hiroshi Ueoka, Katsuyuki Kiura, Takuo Shibayama, Keisuke Aoe, Hiroyuki Kohara, Mine Harada; Establishment of a drug sensitivity panel using human lung cancer cell lines. Acta Med. Okayama 53:67-75(1999) PubMed=15999539 Tadashi Matsumura, Nagio Takigawa, Katsuyuki Kiura, Takuo Shibayama, Masakazu Chikamori, Masahiro Tabata, Hiroshi Ueoka, Mitsune Tanimoto; Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity. In Vivo 19:717-721(2005) |
| Cross-references |
| Encyclopedic resources |
Wikidata; Q93312722
|
| Entry history |
| Entry creation | 25-Feb-2019 |
| Last entry update | 21-Mar-2023 |
| Version number | 4 |
|---|